Clinical Trial

Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in Children

Study acronym: ERADICATE
Unknown Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 31, 2024 (before its estimated November 15, 2024 completion). Its status may not reflect the trial's current state.
Summary
Acute watery diarrhea is defined as the passage of 3 or more loose or liquid stools per day for 3 or more days but less than 14 days, including patients with mild to moderate dehydration per WHO classification. The study's outcome variables are stool frequency, measured by the total number of stools passed during 24 and 48 hours from the initiation of treatment, and hospital duration, measured by the total duration of hospital stay in hours. The null hypothesis states that racecadotril combined with standard treatment has no effect on reducing the mean number of stools passed during 48 hours compared to standard treatment alone in pediatric patients with acute watery diarrhea, while the alternate hypothesis suggests that racecadotril combined with standard treatment will significantly reduce the mean number of stools passed during 48 hours compared to standard treatment alone in these patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06529497
Lead Sponsor Liaquat National Hospital & Medical College
Conditions Diarrhoea
Enrollment 260 participants
Start Date 2024-08-02
Primary Completion 2024-11-15 (estimated)
Study Completion 2024-12-02 (estimated)
Updated on ClinicalTrials.gov 2024-07-31